Can Moderna Rise To The Manufacturing Challenge?

As we've said before, Moderna's (NASDAQ: MRNA) Covid-19 vaccine is likely to emerge as the most sought after vaccine in developed markets, considering its stellar efficacy rates and relative ease of storage. So how is the company going to meet demand? While Moderna intends to produce between...